(Q43744925)

26 November 2017

title

Identification of inhibitor specificity determinants in a mammalian phosphodiesterase (English)

1 reference

26 November 2017

Atienza JM

1

1 reference

26 November 2017

Susanto D

2

1 reference

26 November 2017

Huang C

3

1 reference

26 November 2017

McCarty AS

4

1 reference

26 November 2017

Colicelli J

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

Journal of Biological Chemistry

26 November 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 November 2017

volume

274

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

4839-4847

1 reference

Tailoring cAMP-signalling responses through isoform multiplicity

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Multiplicity within cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Role of multiple cAMP-specific phosphodiesterase variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3',5'-cyclic nucleotide phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Characterization of two recombinant PDE3 (cGMP-inhibited cyclic nucleotide phosphodiesterase) isoforms, RcGIP1 and HcGIP2, expressed in NIH 3006 murine fibroblasts and Sf9 insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Yeast model system for study of mammalian phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Efficient random mutagenesis method with adjustable mutation frequency by use of PCR and dITP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Zardaverine as a selective inhibitor of phosphodiesterase isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Hydropathic analysis and mutagenesis of the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). cGMP versus cAMP substrate selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Stereospecific binding of the antidepressant rolipram to brain protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Role of conserved histidines in catalytic activity and inhibitor binding of human recombinant phosphodiesterase 4A

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

Human recombinant phosphodiesterase 4B2B binds (R)-rolipram at a single site with two affinities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.8.4839

21 January 2018

Identifiers

DOI

10.1074/JBC.274.8.4839

1 reference

26 November 2017

1 reference